Anti-clotting Drug Approved

January 9, 2015 12:30 AM

16 0

The US Food and Drug Administration (FDA), today approved Savaysa (edoxaban tablets), an anti-clotting drug, to treat patients afflicted with atrial fibrillation prone to stroke and severe blood clots, not caused by a heart valve problem.

Additionally, Savaysa had been approved for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) for patients having already been administered anti-clotting injections for a period of 5 to 10 days.

Read more

To category page